Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma

Figure 12

Boxplots showing differences in expression among stem cell-related diagnostic and prognostic genes in each clinical subgroup. (a) Lymphatic invasion. (b) Tumor residual. (c) Tumor status. (d) Venous invasion. (e) FIGO stage. (f) Age. (g) Histologic grade. (h) Primary therapy outcome.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)